Poland· PL-100221904
Vedrop
A tocofersolan product containing tocofersolanum, registered in Poland by Recordati Rare Diseases. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tocofersolan is registered in 11 of 19 countries.
Countries holding a registration under ATC A11HA08 (tocofersolan), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Tocofersolan · ATC A11HA08
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Tocofersolanum
- Manufacturer
- Recordati Rare Diseases
- Country
- Poland (PL)
- ATC code
- A11HA08
- ATC class
- Tocofersolan
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990761050
- gtin05909990761067
- gtin05909990761074
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tocofersolan in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVEDROPRecordati Rare Diseases, Puteaux
- FinlandVedropRecordati Rare Diseases
- FranceVEDROP 50 mg/ml, solution buvableRECORDATI RARE DISEASES
- IrelandVedrop 50 mg/ml Oral solutionRecordati Rare Diseases
- IcelandVedropRecordati Rare Diseases*
- SpainVEDROP 50 MG/ML EN SOLUCION ORALRecordati Rare Diseases
- United KingdomVedrop 50mg/ml oral solutionRecordati Rare Diseases UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/45280640-7a26-4851-b23e-a332432eb044 GET /v1/drugs/45280640-7a26-4851-b23e-a332432eb044?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór doustny",
"source": "urpl",
"strength": "50 mg/ml",
"packaging": "05909990761050 ¦ Rpz ¦ EU/1/09/533/001 ¦ 56019\n1 butelka 10 ml ¦ 1 strzykawka doustna 1 ml\n05909990761067 ¦ Rpz ¦ EU/1/09/533/002 ¦ 56020\n1 butelka 20 ml ¦ 1 strzykawka doustna 1 ml\n05909990761074 ¦ Rpz ¦ EU/1/09/533/003 ¦ 56021\n1 butelka 60 ml ¦ 1 strzykawka doustna 1 ml",
"substance": "Tocofersolanum 50 mg/ml",
"common_name": "Tocofersolanum",
"pl_product_id": "100221904",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about tocofersolan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.